secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIMBERLY CLARK CORP (KMB)
CIK:        0000055785
Form:       8-K
Filed at:   2026-11-02T14:10:51+00:00
Accession:  0001104659-26-120990
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 2.01, 2.05, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Kimberly-Clark closes Kenvue acquisition, issues ~281M shares at 0.14625 ratio plus $3.50 cash per share
--------------------------------------------------------------------------------

- Completed acquisition of Kenvue on Nov. 2, 2026; each Kenvue share converted into 0.14625 KMB shares plus $3.50 cash, with ~281.06M KMB shares issued.
- Board approved Kenvue Integration Program: ~$3.1B cumulative pre-tax charges ($2.5B cash, $0.6B non-cash) through Dec. 31, 2029, plus ~$1.4B capex.
- K-C reiterates anticipated run-rate synergies of $2.1B; combined portfolio includes 10 billion-dollar brands such as Huggies, Listerine, Neutrogena, Tylenol and Kleenex.
- Three Kenvue directors joined K-C board: Richard E. Allison Jr., Larry J. Merlo and Kirk L. Perry; Mae C. Jemison, Christa S. Quarles and Jaime Ramirez resigned to create vacancies.
- One-time premium-priced options granted: Michael Hsu $6.6M, Nelson Urdaneta $2.15M, Jeffrey Melucci $1.8M; exercise price at least $120, vesting Dec. 1, 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55785/000110465926120990/0001104659-26-120990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55785/000110465926120990/tm2628636d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-120990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer